Veraxa Biotech is trading at $2.10 (+6.06%) on July 29, 2026, amid a volatile two-day rebound following a prior pullback.
- The move appears consistent with short-term trading volatility and broader biotech sentiment rather than a specific company announcement or fundamental driver.
- Intraday strength suggests significant rebound buying after recent swings, even as the broader biotech sector remains under pressure.